Scinai Immunotherapeutics Celebrates Dr. Lotti's Award for PC111 Research in Italian Dermatology Scinai Immunotherapeutics proudly announces Dr. Roberta Lotti's recognition for groundbreaking research on PC111. This work marks a significant advancement in autoimmune treatment.

Scinai Immunotherapeutics Celebrates Dr. Lotti's Award for PC111 Research in Italian Dermatology #Scinai_Immunotherapeutics #Israel #Jerusalem #PC111 #Roberta_Lotti